Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration

Chronic low back pain is a critical health problem and a leading cause of disability in aging populations. A major cause of low back pain is considered to be the degeneration of the intervertebral disc (IVD). Recent advances in therapeutics, particularly cell and tissue engineering, offer potential...

Full description

Bibliographic Details
Main Authors: Kennon Justin C., Awad Mohamed E., Chutkan Norman, DeVine John, Fulzele Sadanand
Format: Article
Language:English
Published: De Gruyter 2018-05-01
Series:Biomolecular Concepts
Subjects:
Online Access:https://doi.org/10.1515/bmc-2018-0003
_version_ 1819016102641926144
author Kennon Justin C.
Awad Mohamed E.
Chutkan Norman
DeVine John
Fulzele Sadanand
author_facet Kennon Justin C.
Awad Mohamed E.
Chutkan Norman
DeVine John
Fulzele Sadanand
author_sort Kennon Justin C.
collection DOAJ
description Chronic low back pain is a critical health problem and a leading cause of disability in aging populations. A major cause of low back pain is considered to be the degeneration of the intervertebral disc (IVD). Recent advances in therapeutics, particularly cell and tissue engineering, offer potential methods for inhibiting or reversing IVD degeneration, which have previously been impossible. The use of growth factors is under serious consideration as a potential therapy to enhance IVD tissue regeneration. We reviewed the role of chosen prototypical growth factors and growth factor combinations that have the capacity to improve IVD restoration. A number of growth factors have demonstrated potential to modulate the anabolic and anticatabolic effects in both in vitro and animal studies of IVD tissue engineering. Members of the transforming growth factor-β superfamily, IGF-1, GDF-5, BMP-2, BMP-7, and platelet-derived growth factor have all been investigated as possible therapeutic options for IVD regeneration. The role of growth factors in IVD tissue engineering appears promising; however, further extensive research is needed at both basic science and clinical levels before its application is appropriate for clinical use.
first_indexed 2024-12-21T02:42:18Z
format Article
id doaj.art-a3feeb50cd4445f8833079e82449c014
institution Directory Open Access Journal
issn 1868-5021
1868-503X
language English
last_indexed 2024-12-21T02:42:18Z
publishDate 2018-05-01
publisher De Gruyter
record_format Article
series Biomolecular Concepts
spelling doaj.art-a3feeb50cd4445f8833079e82449c0142022-12-21T19:18:39ZengDe GruyterBiomolecular Concepts1868-50211868-503X2018-05-0191435210.1515/bmc-2018-0003bmc-2018-0003Current insights on use of growth factors as therapy for Intervertebral Disc DegenerationKennon Justin C.0Awad Mohamed E.1Chutkan Norman2DeVine John3Fulzele Sadanand4Department of Orthopaedic Surgery, Augusta University, Augusta, GA, USADepartment of Oral Biology, Augusta University, Augusta, GA, USABanner University Medical Center, University of Arizona College of Medicine – Phoenix, The CORE Institute, Phoenix, AZ, USADepartment of Orthopaedic Surgery, Augusta University, Augusta, GA, USADepartment of Orthopaedic Surgery, Augusta University, Augusta, GA, USAChronic low back pain is a critical health problem and a leading cause of disability in aging populations. A major cause of low back pain is considered to be the degeneration of the intervertebral disc (IVD). Recent advances in therapeutics, particularly cell and tissue engineering, offer potential methods for inhibiting or reversing IVD degeneration, which have previously been impossible. The use of growth factors is under serious consideration as a potential therapy to enhance IVD tissue regeneration. We reviewed the role of chosen prototypical growth factors and growth factor combinations that have the capacity to improve IVD restoration. A number of growth factors have demonstrated potential to modulate the anabolic and anticatabolic effects in both in vitro and animal studies of IVD tissue engineering. Members of the transforming growth factor-β superfamily, IGF-1, GDF-5, BMP-2, BMP-7, and platelet-derived growth factor have all been investigated as possible therapeutic options for IVD regeneration. The role of growth factors in IVD tissue engineering appears promising; however, further extensive research is needed at both basic science and clinical levels before its application is appropriate for clinical use.https://doi.org/10.1515/bmc-2018-0003growth factorintervertebral disctissue engineeringintervertebral disc disease
spellingShingle Kennon Justin C.
Awad Mohamed E.
Chutkan Norman
DeVine John
Fulzele Sadanand
Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration
Biomolecular Concepts
growth factor
intervertebral disc
tissue engineering
intervertebral disc disease
title Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration
title_full Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration
title_fullStr Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration
title_full_unstemmed Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration
title_short Current insights on use of growth factors as therapy for Intervertebral Disc Degeneration
title_sort current insights on use of growth factors as therapy for intervertebral disc degeneration
topic growth factor
intervertebral disc
tissue engineering
intervertebral disc disease
url https://doi.org/10.1515/bmc-2018-0003
work_keys_str_mv AT kennonjustinc currentinsightsonuseofgrowthfactorsastherapyforintervertebraldiscdegeneration
AT awadmohamede currentinsightsonuseofgrowthfactorsastherapyforintervertebraldiscdegeneration
AT chutkannorman currentinsightsonuseofgrowthfactorsastherapyforintervertebraldiscdegeneration
AT devinejohn currentinsightsonuseofgrowthfactorsastherapyforintervertebraldiscdegeneration
AT fulzelesadanand currentinsightsonuseofgrowthfactorsastherapyforintervertebraldiscdegeneration